Abstrakt

Przypisy

• 1. Berger J.R., Nath A., Greenberg R.N., Andersen A.H., Greene R.A.,Bognar A., Avison M.J.: Cerebrovascular changes in the basal gangliawith HIV dementia. Neurology, 2000; 54: 921-926
  Google Scholar
• 2. Brown L.L., Schneider J.S., Lidsky T.I.: Sensory and cognitive functionsof the basal ganglia. Cur. Opin. Neurobiol., 1997; 7: 157-163
  Google Scholar
• 3. Ferrari A., Coccia C.P., Bertolini A., Sternieri E.: Methadone -metabolism, pharmacokinetics and interactions. Pharmacol. Res.,2004; 50: 551-559
  Google Scholar
• 4. Fiellin D.A.: Substance use disorders in HIV-infected patients:impact and new treatment strategies. Top. HIV Med., 2004; 12: 77-82
  Google Scholar
• 5. Fukui H., Murai T., Fukuyama H., Hayashi T., Hanakawa T.: Functionalactivity related to risk anticipation during performance of theIowa Gambling Task. Neuroimage, 2005; 24: 253-259
  Google Scholar
• 6. Goldsmith P., Jones R.E., Ozuzu G.E., Richardson J., Ong E.L.: Opticneuropathy as the presenting feature of HIV infection: recovery ofvision with highly active antiretroviral therapy. Br. J. Ophthalmol.,2000; 84: 551-553
  Google Scholar
• 7. Gorzelańczyk E.J.: Functional anatomy, physiology and cliniqueof basal ganglia. In: Neuroimaging for Clinicians – Combining Researchand Practice, 2011, 89-106
  Google Scholar
• 8. Gorzelańczyk E.J.: Neurobiological sources of addiction – evolutionaryand clinical perspective. Alkoholizm i Narkomania, 2011; 24: 235-249
  Google Scholar
• 9. Jabs D.A., Green W.R., Fox R., Polk B.F., Bartlett J.G.: Ocular manifestationsof acquired immune deficiency syndrome. Ophthalmology,1989; 96: 1092-1099
  Google Scholar
• 10. Jernigan T.L., Gamst A.C., Archibald S.L., Fennema-NotestineC., Mindt M.R., Marcotte T.D., Heaton R.K., Ellis R.J., Grant I.: Effectsof methamphetamine dependence and HIV infection on cerebralmorphology. Am. J. Psychiatry, 2005; 162: 1461-1472
  Google Scholar
• 11. Johnson R.E., Chutuape M.A., Strain E.C., Walsh S.L., Stitzer M.L., BigelowG.E.: A comparison of levomethadyl acetate, buprenorphine, andmethadone for opioid dependence. N. Engl. J. Med., 2000; 343: 1290-1297
  Google Scholar
• 12. Keane J.R.: Neuro-ophthalmologic signs of AIDS: 50 patients.Neurology, 1991; 41: 841-845
  Google Scholar
• 13. Khalsa J., Genser S., Vocci F., Francis H., Bean P.: The challenginginteractions between antiretroviral agents and addiction drugs. Am.Clin. Lab., 2002; 21: 10-13
  Google Scholar
• 14. Kharasch E.D., Walker A., Whittington D., Hoffer C., BedynekP.S.: Methadone metabolism and clearance are induced by nelfinavirdespite inhibition of cytochrome P4503A (CYP3A) activity. DrugAlcohol Depend., 2009; 101: 158-168
  Google Scholar
• 15. Larsen M., Toft P.B., Bernhard P., Herning M.: Bilateral opticneuritis in acute human immunodeficiency virus infection. ActaOphthalmol. Scand., 1998; 76: 737-738
  Google Scholar
• 16. Laskowska I., Gorzelańczyk E.J.: Rola jąder podstawy w regulacjifunkcji poznawczych. Neuropsychiatr. Neuropsychol., 2009; 4: 26-35
  Google Scholar
• 17. Leigh R.L., Zee D.S.: The neurology of eye movements. Oxford2006
  Google Scholar
• 18. McCance-Katz E.F., Gourevitch M.N., Arnsten J., Sarlo J., RaineyP., Jatlow P.: Modified directly observed therapy (MDOT) for injectiondrug users with HIV disease. Am. J. Addict., 2002; 11: 271-278
  Google Scholar
• 19. Meyer P.J., Meshul C.K., Phillips T.J.: Ethanol- and cocaine-inducedlocomotion are genetically related to increases in accumbaldopamine. Genes Brain Behav., 2009; 8: 346-55
  Google Scholar
• 20. Mwanza J.C., Nyamabo L.K., Tylleskär T., Plant G.T.: Neuro-ophthalmologicaldisorders in HIV infected subjects with neurologicalmanifestations. Br. J. Ophthalmol, 2004; 88: 1455-1459
  Google Scholar
• 21. Nath A., Maragos W.F., Avison M.J., Schmitt F.A., Berger J.R.: Accelerationof HIV dementia with methamphetamine and cocaine. J.Neurovirol., 2001; 7: 66-71
  Google Scholar
• 22. Noorani I., Carpenter R.H.: Antisaccades as decisions: LATERmodel predicts latency distributions and error responses. Eur. J.Neurosci., 2013; 37: 330-338
  Google Scholar
• 23. Ober J.K., Przedpelska-Ober E., Gryncewicz W., Dylak J., CarpenterR.S., Ober J.J.: Hand-held system for ambulatory measurementof saccadic durations of neurological patients. In: Gadja J. (ed.), Modellingand Measurement in Med., 2003; 187-198
  Google Scholar
• 24. Pearson B.C., Armitage K.R., Horner C.W., Carpenter R.H.: Saccadometry:the possible application of latency distribution measurementfor monitoring concussion. Br. J. Sports Med., 2007; 41:610-612
  Google Scholar
• 25. Perez Pons J.C., Jornet Montana S., Bonet Esteve A.: Pharmacokineticinteractions between methadone and antiretroviral medicationin HIV positive patients. Med. Clin. 2002; 119: 224-229
  Google Scholar
• 26. Pirastu R., Fais R., Messina M., Bini V., Spiga S., Falconieri D.,Diana M.: Impaired decision-making in opiate-dependent subjects:effect of pharmacological therapies. Drug Alcohol Depend., 2006;83: 163-168
  Google Scholar
• 27. Reyes M.G., Faraldi F., Senseng C.S., Flowers C., Fariello R.: Nigraldegeneration in acquired immune deficiency syndrome (AIDS). ActaNeuropathol., 1991; 82: 39-44
  Google Scholar
• 28. Rippeth J.D., Heaton R.K., Carey C.L., Marcotte T.D., Moore D.J.,Gonzalez R., Wolfson T., Grant I., HNRC Group: Methamphetaminedependence increases risk of neuropsychological impairment in HIVinfected persons. J. Int. Neuropsychol. Soc., 2004; 10: 1-14
  Google Scholar
• 29. Ross S., Peselow E.: The neurobiology of addictive disorders.Clin. Neuropharmacol., 2009; 32: 269-276
  Google Scholar
• 30. Thompson P.M., Dutton R.A., Hayashi K.M., Toga A.W., LopezO.L., Aizenstein H.J., Becker J.T.: Thinning of the cerebral cortex visualizedin HIV/AIDS reflects CD4+ T lymphocyte decline. Proc. Natl.Acad. Sci. USA, 2005; 102: 15647-15652
  Google Scholar
• 31. Valcour V., Sithinamsuwan P., Letendre S., Ances B.: Pathogenesis ofHIV in the central nervous system. Curr. HIV/AIDS Rep., 2011; 8: 54-61
  Google Scholar
• 32. Vastag B.: Health agencies update. HIV and heroin interactions.J. Am. Med. Assoc., 2001; 286: 295
  Google Scholar
• 33. Wallace D.R.: HIV neurotoxicity: potential therapeutic interventions.J. Biomed. Biotechnol., 2006; 2006: 65741
  Google Scholar

Pełna treść artykułu